Table 2.
Clinical Variables of the Study Participants (n=242)
| Characteristics | Frequency | Percent | |
|---|---|---|---|
| Antipsychotic medicationsa | |||
| Chlorpromazine oral tablet | 167 | 69 | |
| Haloperidol oral tablet | 37 | 15.3 | |
| Fluphenazine decanoate depot | 164 | 67 | |
| Other medications used | 14 | 5.7 | |
| Promethazine | 10 | 4.1 | |
| Trihexyphenidyl | 2 | 0.8 | |
| Diazepam | 2 | 0.8 | |
| Number of antipsychotics | |||
| Single | 123 | 50.83 | |
| Multiple | 119 | 49.17 | |
| Counseling on ADRs | |||
| Yes | 122 | 50.4 | |
| No | 120 | 49.6 | |
| Insight | |||
| Poor insight | 53 | 21.9 | |
| Partial insight | 60 | 24.8 | |
| Good insight | 129 | 53.3 | |
| Characteristics | Min, Max | Mean, SD | Median, IQR |
| Duration of illness (months) | 3, 651 | 157.90, 112.44 | 147, 75 |
| Antipsychotic dose (mg/day, chlorpromazine equivalents) | 48.08, 792.31 | 244.64, 147.61 | 196.15, 200 |
Note: aParticipants can select more than one response.
Abbreviations: IQR, inter quartile range; SD, standard deviation; Min, minimum; Max, maximum; n, number of participant.